IL6 and COVID-19: Our study focused on IL-6 due to its reported unique role in the cytokine storm occurring in patients with COVID-19, its good correlation to disease severity, the risk of needing mechanical ventilation, or death, and most importantly, because it can be used as a pharmacological target (14, 17, 25, 28–31, 36, 37).